WiSys Technologies

24 WiSys Technologies in "Pharmaceuticals & Vitamin D" or "Information Technology" or "Agriculture" or "Food & Supplements" or "Engineering" or "Diagnostic Assays"

Optimized Method for the Aqueous Extraction of Anthocyanins from Fruit Waste

WiSys is seeking a strategic partner interested in providing a route to market for the commercialization and use of this anthocyanin extraction system.  There is also interest in partnering with a fruit processing company for the continued testing and scaling of this system.

Semiconductor Quantum Dot Computer Aided Engineering (CAE) Simulation Tool

WiSys is seeking a strategic partner skilled in the design, modeling, and fabrication of Quantum Dots and Quantum wires.  There is interest in working with a partner to test the beta version of the CAE simulation tool and provide feedback when modeling both Quantum Wires and Quantum Dots.  Additionally, there is interest in identifying a partner with a 3D finite element method solver for further development and testing of the CAE simulation tool.

Health Monitoring and Imaging System for Concrete Structures

WiSys is currently seeking strategic partners operating in the non-destructive testing industry interested in further developing this novel health monitoring system for concrete structures, ultimately providing a route to market for its commercialization.

Porous Silicon Nanomembranes for the Rapid Separation of Macromolecules by Size and Shape

WiSys is seeking a strategic partner skilled in the development and manufacturing of membranes used for the separation and/or detection of biologic molecules in solution.  There is additional interest in a partner with the expertise to identify and test novel applications for these nanomembranes.

Wind Shield to Improve Overwinter Beehive Survival

WiSys is seeking a strategic commercial partner for development of this beehive wind shield for mass manufacturing, as well as partners for marketing, sales, and distribution.

Skin Whitening Agent(s)

WiSys Technology Foundation is currently seeking a strategic industry partner to assist in the further development of its lead compound, A11, and related analogues providing a route to market for their use as novel skin whitening/lightening agents.The competitive advantage of these compounds over existing agents on the market is that they produce long-acting and reversible skin lightening with no toxicity.

Benzodiazepine Derivatives with Reduced Side Effects

The WiSys Technology Foundation is seeking commercial partners interested in developing anxiolytic and anticonvulsant benzodiazepines that offer little or no side effects.